创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06628 创胜集团-B

已收盘 12-19 16:08:47

0.600

+0.000

0.00%

最高0.670	最低0.600	成交量12.74万
今开0.600	昨收0.600	日振幅11.67%
总市值2.60亿	流通市值2.60亿	总股本4.34亿
成交额7.72万	换手率0.03%	流通股本4.34亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06628","market":"HK","secType":"STK","nameCN":"创胜集团-B","latestPrice":0.6,"timestamp":1734595727019,"preClose":0.6,"halted":0,"volume":127400,"delay":0,"floatShares":434000000,"shares":434000000,"eps":-1.2190878,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"12-19 16:08:47","open":0.6,"high":0.67,"low":0.6,"amount":77215,"amplitude":0.116667,"askPrice":0.64,"askSize":12000,"bidPrice":0.57,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.9476176778899239,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1632844800000,"adjPreClose":0.6,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.708171,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06628","defaultTab":"news","newsList":[{"id":"2492219997","title":"创胜集团-B股价拉升11.67% 市值涨3395.15万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492219997","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492219997?lang=zh_cn&edition=full","pubTime":"2024-12-19 10:39","pubTimestamp":1734575993,"startTime":"0","endTime":"0","summary":"2024年12月19日早盘10时39分，创胜集团-B股票出现异动，股价急速拉升11.67%。资金方面，该股资金流入8395港元，流出0港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。创胜集团-B股票所在的生物技术行业中，整体跌幅为1.12%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219103953ab834e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219103953ab834e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2492954199","title":"创胜集团－Ｂ(06628)股价显著上升11.667%，现价港币$0.67","url":"https://stock-news.laohu8.com/highlight/detail?id=2492954199","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492954199?lang=zh_cn&edition=full","pubTime":"2024-12-19 10:39","pubTimestamp":1734575940,"startTime":"0","endTime":"0","summary":"[上升股]创胜集团－Ｂ(06628) 股价在上午10:39比前收市价显著上升11.667%，现股价为港币$0.67。至目前为止，今日最高价为$0.67，而最低价为$0.6。总成交量为1.3万股，总成交金额为港币$8395。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241219587/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2492343188","title":"钱雪明增持创胜集团-B(06628)1.25万股 每股作价0.636港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492343188","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492343188?lang=zh_cn&edition=full","pubTime":"2024-12-18 20:47","pubTimestamp":1734526079,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，12月13日，钱雪明增持创胜集团-B(06628)1.25万股，每股作价0.636港元，总金额0.795万港元。增持后最新持股数目约为3742.5万股，最新持股比例为8.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2492928144","title":"创胜集团-B盘中异动 早盘股价大涨8.62%报0.630港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492928144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492928144?lang=zh_cn&edition=full","pubTime":"2024-12-18 11:29","pubTimestamp":1734492587,"startTime":"0","endTime":"0","summary":"2024年12月18日早盘11时29分，创胜集团-B股票出现波动，股价快速上涨8.62%。截至发稿，该股报0.630港元/股，成交量3500股，换手率0.00%，振幅15.52%。资金方面，该股资金流入1760港元，流出0港元。创胜集团-B股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，歌礼制药-B、北海康成-B、创胜集团-B涨幅较大，振幅较大的相关个股有北海康成-B、圣诺医药-B、歌礼制药-B，振幅分别为28.66%、19.06%、18.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218112947984ca000&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218112947984ca000&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2492498379","title":"新型LIV-1 ADCs抗肿瘤活性显著！创胜集团为乳腺癌治疗带来新希望","url":"https://stock-news.laohu8.com/highlight/detail?id=2492498379","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492498379?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:33","pubTimestamp":1734485630,"startTime":"0","endTime":"0","summary":"研究结果显示，ADC-1和ADC-2这两款抗体偶联药物在三阴性乳腺癌肿瘤模型中展现出显著的肿瘤消退活性，而以MMAE为细胞毒素的ADC却未能使肿瘤消退。复发或转移性三阴性乳腺癌通常预后较差，5年生存率不足15%，显著低于乳腺癌患者整体5年生存率。而根据全球癌症统计数据，2022年全球女性乳腺癌新发病例为231万。根据弗若斯特沙利文统计中国乳腺癌新发病例数呈现逐年上升趋势。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MmE5ZmExMjY0NjZiOTEwNWRjYzNhYzE1NWFlMjE2MzgxNTIxMjk2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmE5ZmExMjY0NjZiOTEwNWRjYzNhYzE1NWFlMjE2MzgxNTIxMjk2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","000876","BK0183","BK0188","LIV","06628","BK0196","BK0028","BK1161","BK0187","BK0238"],"gpt_icon":0},{"id":"2491482686","title":"创胜集团-B盘中异动 股价大跌18.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491482686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491482686?lang=zh_cn&edition=full","pubTime":"2024-12-16 09:34","pubTimestamp":1734312857,"startTime":"0","endTime":"0","summary":"2024年12月16日早盘09时34分，创胜集团-B股票出现异动，股价大幅下跌18.03%。截至发稿，该股报0.500港元/股，成交量2.35万股，换手率0.01%，振幅18.03%。创胜集团-B股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，云康集团、晶泰控股-P、云顶新耀-B涨幅较大，振幅较大的相关个股有创胜集团-B、晶泰控股-P、康诺亚-B，振幅分别为18.03%、5.84%、4.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093417ab7afb47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093417ab7afb47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2491319800","title":"创胜集团-B盘中异动 急速拉升6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491319800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491319800?lang=zh_cn&edition=full","pubTime":"2024-12-13 13:57","pubTimestamp":1734069457,"startTime":"0","endTime":"0","summary":"2024年12月13日下午盘13时57分，创胜集团-B股票出现波动，股价大幅拉升6.67%。截至发稿，该股报0.640港元/股，成交量30.25万股，换手率0.07%，振幅5.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。创胜集团-B股票所在的生物技术行业中，整体跌幅为0.54%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121313573795e95ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121313573795e95ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2491965963","title":"晶泰控股-P盘中异动 早盘急速跳水17.89%报3.580港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491965963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491965963?lang=zh_cn&edition=full","pubTime":"2024-12-13 09:30","pubTimestamp":1734053407,"startTime":"0","endTime":"0","summary":"2024年12月13日早盘09时30分，晶泰控股-P股票出现异动，股价急速跳水17.89%。截至发稿，该股报3.580港元/股，成交量1045.5万股，换手率0.31%，振幅4.82%。资金方面，该股资金流入296.453万港元，流出295.399万港元。晶泰控股-P股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，创胜集团-B、百奥赛图-B、科济药业-B涨幅较大，振幅较大的相关个股有晶泰控股-P、思路迪医药股份、药明合联，振幅分别为4.82%、2.29%、1.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121309300795e94e23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121309300795e94e23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1141","02228","06628"],"gpt_icon":0},{"id":"2491097383","title":"创胜集团于2024 SABCS上首次公布新型LIV-1 ADCs用于治疗三阴性乳腺癌的临床前数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2491097383","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491097383?lang=zh_cn&edition=full","pubTime":"2024-12-13 08:07","pubTimestamp":1734048420,"startTime":"0","endTime":"0","summary":"ADC-1和ADC-2这两款抗体偶联药物使用创胜集团专有抗体，通过定点偶联拓扑异构酶I抑制剂载荷进行设计。LIV-1是锌转运蛋白家族的成员，也是转移性乳腺癌中的一个雌激素调控基因。这使得LIV-1成为一个在开发ADC疗法时值得注意的细胞表面靶点。\" 创胜集团董事会主席兼首席执行官钱雪明博士表示，\"这些数据为我们进一步研究LIV-1 ADCs提供了依据，该抗体偶联药物有望成为LIV-1阳性乳腺癌和其他实体瘤潜在的下一代治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4578508_ZH78508_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["06628","BK1161","LIV"],"gpt_icon":0},{"id":"2491362436","title":"创胜集团(06628.HK)于美国发表治疗乳腺癌药物临床前研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2491362436","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491362436?lang=zh_cn&edition=full","pubTime":"2024-12-13 08:06","pubTimestamp":1734048360,"startTime":"0","endTime":"0","summary":"创胜集团-B(06628.HK) 公布，于2024年圣安东尼奥乳腺癌研讨会(SABCS)，发表基于人源化LIV-1抗体的新型抗体偶联药物(ADC)的最新临床前研究结果。据介绍，ADC-1和ADC-2这两款抗体偶联药物使用该公司专有抗体，通过位点特异性结合拓扑异构酶I抑制剂载荷进行设计。这两款抗体偶联药物在三阴性乳腺癌(TNBC)肿瘤模型中展现出的肿瘤消退活性，显著高于基于MMAE的ADC。(js/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220216154456656_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220216154456656_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1403848/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2491361804","title":"智通港股早知道 | 中央经济工作会议举行 越疆(02432)拟全球发售约4000万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2491361804","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491361804?lang=zh_cn&edition=full","pubTime":"2024-12-13 07:52","pubTimestamp":1734047536,"startTime":"0","endTime":"0","summary":"中央经济工作会议：明年要大力提振消费 提高投资效益全方位扩大国内需求中央经济工作会议12月11日至12日在北京举行。中央经济工作会议：持续用力推动房地产市场止跌回稳据央视新闻联播，中央经济工作会议12月11日至12日在北京举行。越疆拟全球发售约4000万股股份 预计全球发售净筹约7.2亿港元智通财经APP讯，越疆于2024年12月13日-12月18日招股，拟全球发售约4000万股股份，香港公开发售占5%，国际发售占95%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06628","HSCEI","HSTECH","01318","BK1161","YANG"],"gpt_icon":1},{"id":"2491544363","title":"创胜集团-B(06628)于有关2024 SABCS上公布新型LIV-1 ADCs用于治疗三阴性乳腺癌模型中的抗肿瘤效果的最新业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2491544363","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491544363?lang=zh_cn&edition=full","pubTime":"2024-12-13 06:36","pubTimestamp":1734042968,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团-B 发布公告，2024年圣安东尼奥乳腺癌研讨会 发表了基于人源化LIV-1抗体的新型抗体偶联药物的最新临床前研究结果。ADC-1和ADC-2这两款抗体偶联药物使用公司专有抗体，通过位点特异性结合拓扑异构酶I抑制剂载荷进行设计。这两款抗体偶联药物在三阴性乳腺癌肿瘤模型中展现出的肿瘤消退活性，显著高于基于MMAE的ADC。LIV-1是锌转运蛋白家族的成员，也是转移性乳腺癌中的一个雌激素调控基因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LIV","06628"],"gpt_icon":0},{"id":"2490821250","title":"创胜集团-B盘中异动 股价大涨8.20%报0.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490821250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490821250?lang=zh_cn&edition=full","pubTime":"2024-12-12 13:35","pubTimestamp":1733981740,"startTime":"0","endTime":"0","summary":"2024年12月12日下午盘13时35分，创胜集团-B股票出现异动，股价快速上涨8.20%。截至发稿，该股报0.660港元/股，成交量18.75万股，换手率0.04%，振幅9.84%。资金方面，该股资金流入9.502万港元，流出1.984万港元。创胜集团-B股票所在的生物技术行业中，整体跌幅为0.35%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212133540ab7185b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212133540ab7185b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2490037105","title":"创胜集团-B盘中异动 股价大跌6.15%报0.610港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490037105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490037105?lang=zh_cn&edition=full","pubTime":"2024-12-10 10:04","pubTimestamp":1733796246,"startTime":"0","endTime":"0","summary":"2024年12月10日早盘10时04分，创胜集团-B股票出现异动，股价大幅下挫6.15%。截至发稿，该股报0.610港元/股，成交量2500股，换手率0.00%，振幅6.15%。资金方面，该股资金流入1300港元，流出305港元。创胜集团-B股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，科济药业-B、思路迪医药股份、歌礼制药-B涨幅较大，振幅较大的相关个股有华康生物医学、晶泰控股-P、药明巨诺-B，振幅分别为12.50%、11.30%、10.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210100406ab6b68b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210100406ab6b68b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2490714725","title":"创胜集团-B盘中异动 临近收盘大幅下挫5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490714725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490714725?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:38","pubTimestamp":1733729939,"startTime":"0","endTime":"0","summary":"2024年12月09日临近收盘15时38分，创胜集团-B股票出现波动，股价急速跳水5.97%。创胜集团-B股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，永泰生物-B、药明合联、嘉和生物-B涨幅较大，振幅较大的相关个股有晶泰科技、永泰生物-B、华康生物医学，振幅分别为25.30%、21.91%、19.26%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120915385998e6765d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120915385998e6765d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2489432641","title":"创胜集团-B(06628)12月5日斥资4.97万港元回购6.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489432641","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489432641?lang=zh_cn&edition=full","pubTime":"2024-12-05 19:38","pubTimestamp":1733398681,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团-B(06628)发布公告，于2024年12月5日斥资4.97万港元回购股份6.9万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2489706631","title":"创胜集团-B盘中异动 早盘快速下挫5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489706631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489706631?lang=zh_cn&edition=full","pubTime":"2024-12-05 09:51","pubTimestamp":1733363468,"startTime":"0","endTime":"0","summary":"2024年12月05日早盘09时51分，创胜集团-B股票出现波动，股价大幅下跌5.48%。创胜集团-B股票所在的生物技术行业中，整体跌幅为1.16%。其相关个股中，帝王国际投资、药明巨诺-B、晶泰科技涨幅较大，振幅较大的相关个股有晶泰科技、药明巨诺-B、腾盛博药-B，振幅分别为15.84%、9.92%、9.78%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120509510898e579a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120509510898e579a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2488391471","title":"创胜集团-B股价飙升28.57% 市值涨1.12亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488391471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488391471?lang=zh_cn&edition=full","pubTime":"2024-12-04 13:58","pubTimestamp":1733291892,"startTime":"0","endTime":"0","summary":"2024年12月04日下午盘13时58分，创胜集团-B股票出现异动，股价快速上涨28.57%。截至发稿，该股报0.900港元/股，成交量16.7万股，换手率0.04%，振幅32.86%。资金方面，该股资金流入4.274万港元，流出6.968万港元。创胜集团-B股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，晶泰科技、方达控股、华康生物医学涨幅较大，振幅较大的相关个股有晶泰科技、来凯医药-B、云顶新耀-B，振幅分别为17.71%、10.29%、10.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204135813971b87d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204135813971b87d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2488891363","title":"钱雪明增持创胜集团-B(06628)5万股 每股作价0.64港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488891363","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488891363?lang=zh_cn&edition=full","pubTime":"2024-12-03 19:27","pubTimestamp":1733225230,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月28日，钱雪明增持创胜集团-B(06628)5万股，每股作价0.64港元，总金额3.2万港元。增持后最新持股数目约为3735.05万股，最新持股比例为8.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2487658361","title":"创胜集团-B股价上涨12.50% 市值涨3908.63万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487658361","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487658361?lang=zh_cn&edition=full","pubTime":"2024-11-29 14:44","pubTimestamp":1732862666,"startTime":"0","endTime":"0","summary":"2024年11月29日下午盘14时44分，创胜集团-B股票出现异动，股价急速拉升12.50%。截至发稿，该股报0.720港元/股，成交量6500股，换手率0.00%，振幅12.50%。资金方面，该股资金流入4200港元，流出0港元。创胜集团-B股票所在的生物技术行业中，整体涨幅为1.52%。其相关个股中，创胜集团-B、东曜药业-B、百济神州涨幅较大，振幅较大的相关个股有北海康成-B、创胜集团-B、宜明昂科-B，振幅分别为13.85%、12.50%、12.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129144426971a956d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129144426971a956d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06628","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transcenta.com","stockEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":-0.2857},{"period":"3month","weight":-0.4},{"period":"6month","weight":-0.5745},{"period":"1year","weight":-0.7857},{"period":"ytd","weight":-0.8329}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的投资控股公司。该公司的产品包括MSB2311，TST001，TST005，TST002，TST004，TST003，TST008，MSB0254和TST006。该公司还提供合同开发和生产（CDMO）服务，主要包括工艺开发服务、GMP/cGMP生产服务、细胞株开发服务、样品检测服务、配方优化服务及成药性研究。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.126943},{"month":2,"riseRate":0,"avgChangeRate":-0.198068},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.052925},{"month":4,"riseRate":0.666667,"avgChangeRate":0.18192},{"month":5,"riseRate":0.333333,"avgChangeRate":0.016347},{"month":6,"riseRate":0,"avgChangeRate":-0.105513},{"month":7,"riseRate":0,"avgChangeRate":-0.115708},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.070228},{"month":9,"riseRate":0.333333,"avgChangeRate":0.006161},{"month":10,"riseRate":0.25,"avgChangeRate":-0.099504},{"month":11,"riseRate":0,"avgChangeRate":-0.139784},{"month":12,"riseRate":0.25,"avgChangeRate":-0.063815}],"exchange":"SEHK","name":"创胜集团-B","nameEN":"TRANSCENTA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创胜集团-B(06628)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创胜集团-B,06628,创胜集团-B股票,创胜集团-B股票老虎,创胜集团-B股票老虎国际,创胜集团-B行情,创胜集团-B股票行情,创胜集团-B股价,创胜集团-B股市,创胜集团-B股票价格,创胜集团-B股票交易,创胜集团-B股票购买,创胜集团-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创胜集团-B(06628)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}